REPR - Repro Med Systems, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
2/27/2017
2/28/2016
Total Revenue
21,211
17,354
15,443
12,294
12,247
Cost of Revenue
7,591
6,543
6,175
4,724
4,644
Gross Profit
13,620
10,810
9,268
7,570
7,603
Operating Expenses
Research Development
531
241
89
237
207
Selling General and Administrative
9,966
9,096
7,732
7,768
5,943
Total Operating Expenses
10,830
9,646
8,127
8,306
6,422
Operating Income or Loss
2,791
1,165
1,141
-736
1,181
Interest Expense
-
-
-
2
13
Total Other Income/Expenses Net
-2,457
-16
69
-41
-26
Income Before Tax
407
1,177
1,210
-777
1,143
Income Tax Expense
118
266
391
-242
360
Income from Continuing Operations
289
911
820
-535
783
Net Income
289
911
820
-535
783
Net Income available to common shareholders
289
911
820
-535
783
Reported EPS
Basic
-
0.02
0.02
-0.01
0.02
Diluted
-
0.02
0.02
-0.01
0.02
Weighted average shares outstanding
Basic
-
38,128
37,874
37,831
37,989
Diluted
-
38,922
38,394
37,878
37,989
EBITDA
-
1,474
1,448
-474
1,427